Mebix Inc   Report issue

For profit Phase 4
Founded: Tokyo Japan (2001)

Organization Overview

First Clinical Trial
2013
NCT02137733
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Mebix Inc